2015 Annual Meeting | Treating Dementia in an Age of Mixed Disease
| 02:00 PM - 02:05 PM |
Introduction
|
|
| 02:00 PM - 06:00 PM | Abstract |
002 - Mixed Membership Trajectory Model of Cognitive Impairment in the Cardiovascular Health Study - Cognition Study
|
| 02:00 PM - 06:00 PM | Abstract |
003 - Neuroticism Increases with Age in Cognitively Normal Older Adults who are PiB-Positive
Carolyn Fredericks, MD |
| 02:00 PM - 06:00 PM | Abstract |
004 - Relation of cognitive impairment and insulin resistance in Hispanic patients with Parkinson’s disease.
Angel Vinuela Cabezas De Herrera, MD |
| 02:00 PM - 06:00 PM | Abstract |
005 - Early Diagnosis of Vascular Cognitive Impairment is Associated with Improved Adherence with Medical Treatment of Vascular Risk Factors
Angelia Kirkpatrick |
| 02:00 PM - 06:00 PM | Abstract |
006 - Anti-S100B autoantibodies in cerebral small vessel disease
Chanda Brennan |
| 02:00 PM - 06:00 PM | Abstract |
007 - The Neuropathology of Patients with Dementia and Non-Dementia in the Oldest-old
GAMZE BALCI CAMSARI, MD |
| 02:00 PM - 06:00 PM | Abstract |
008 - White matter hyperintensity associated with cerebral amyloidosis independent of hypertension history
|
| 02:00 PM - 06:00 PM | Abstract |
009 - Differential Progression of White Matter Hyperintensities in Early-Onset compared to Late-Onset Alzheimer’s Disease: a Longitudinal MRI Study
Nicodemus E. Oey |
| 02:00 PM - 06:00 PM | Abstract |
010 - Heart-Heath Intervention reduces cognitive decline in mild cognitive impairment of the cerebrovascular type: a randomized, placebo-controlled clinical trial
Gregory A. Jicha, MD, PhD |
| 02:00 PM - 06:00 PM | Abstract |
011 - The Association between Pulse Pressure and Memory Functioning over time Depends on Baseline Systolic Blood Pressure
Eric M. McDade, DO |
| 02:00 PM - 06:00 PM | Abstract |
012 - Sleep duration is associated with worse neurocognitive function in Hispanic/Latinos: Results of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Alberto Ramos, MD, FAAN |
| 02:00 PM - 06:00 PM | Abstract |
013 - The association of sleep apnea and stroke with cognitive performance: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
Jennifer R. Molano, MD, FAAN |
| 02:05 PM - 02:35 PM |
Cellular Mechanisms that Link Alzheimer’s Disease and Vascular Dementia
Berislav V. Zlokovic, MD, PhD |
|
| 02:35 PM - 02:40 PM |
Anti-S100B Autoantibodies in Cerebral Small Vessel Disease
Chanda Brennan |
|
| 02:40 PM - 02:45 PM |
The Neuropathology of Patients with Dementia and Non-Dementia in the Oldest-old
GAMZE BALCI CAMSARI, MD |
|
| 02:45 PM - 02:55 PM |
Audience Q&A
|
|
| 02:55 PM - 03:25 PM |
Reconsidering Harbingers of Alzheimer’s disease: Risk factors, Biomarkers, and White Matter Hyperintensities
Adam Brickman, PhD |
|
| 03:25 PM - 03:30 PM |
White Matter Hyperintensity Associated with Cerebral Amyloidosis Independent of Hypertension History
|
|
| 03:30 PM - 03:35 PM |
Differential Progression of White Matter Hyperintensities in Early-Onset compared to Late-Onset Alzheimer’s Disease: a Longitudinal MRI Study
Nicodemus E. Oey |
|
| 03:35 PM - 03:45 PM |
Audience Q&A
|
|
| 03:45 PM - 03:55 PM |
Break
|
|
| 03:55 PM - 04:25 PM |
Blood Pressure Management in Vascular Cognitive Impairment
Randolph S. Marshall, MD, FAAN |
|
| 04:25 PM - 04:30 PM |
Heart-Heath Intervention Reduces Cognitive Decline in Mild Cognitive Impairment of the Cerebrovascular Type: A Randomized, Placebo-Controlled Clinical Trial
Gregory A. Jicha, MD, PhD |
|
| 04:30 PM - 04:35 PM |
The Association between Pulse Pressure and Memory Functioning over Time Depends on Baseline Systolic Blood Pressure
Eric M. McDade, DO |
|
| 04:35 PM - 04:45 PM |
Audience Q&A
|
|
| 04:45 PM - 05:15 PM |
Sleep and Alzheimer's disease: A Bi-Directional Relationship
David M. Holtzman, MD, FAAN |
|
| 05:15 PM - 05:20 PM |
Sleep Duration is associated with Worse Neurocognitive Function in Hispanic/Latinos: Results of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Alberto Ramos, MD, FAAN |
|
| 05:20 PM - 05:25 PM |
The Association of Sleep Apnea and Stroke with Cognitive Performance: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Jennifer R. Molano, MD, FAAN |
|
| 05:25 PM - 05:35 PM |
Audience Q&A
|
|
| 05:35 PM - 06:00 PM |
Guided Poster Rounds
|
| Randolph S. Marshall, MD, FAAN | The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
| Ronald M. Lazar, PhD, FAHA, FAAN, FAAN | Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care. |
| Jennifer R. Molano, MD, FAAN | Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health. Dr. Molano has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer for an educational podcast series with The Teaching Company. |
| Eric M. McDade, DO | Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondation Alzheimer. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer. |
| David M. Holtzman, MD, FAAN | No disclosure on file |
| GAMZE BALCI CAMSARI, MD | No disclosure on file |
| Nicodemus E. Oey | No disclosure on file |
| Chanda Brennan | No disclosure on file |
| No disclosure on file | |
| Berislav V. Zlokovic, MD, PhD | No disclosure on file |
| Adam Brickman, PhD | Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition Therapeutics. |
| Alberto Ramos, MD, FAAN | Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities. |
| Gregory A. Jicha, MD, PhD | Dr. Jicha has nothing to disclose. |
| James T. Becker, PhD | No disclosure on file |
| William W. Seeley, MD | Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative. |
| Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Ralph L. Sacco, MD, MS, FAHA | Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care. |
| Phyllis C. Zee, MD, PhD | Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care. |
| Elliott D. Ross, MD, FAAN | No disclosure on file |
| Dawn O. Kleindorfer, MD, FAAN | Dr. Kleindorfer has nothing to disclose. |
| Virginia Sturm, PhD | Dr. Sturm has nothing to disclose. |
| Calin I. Prodan, MD | The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340). |
| Susan M. Resnick, PhD | No disclosure on file |
| Angel Vinuela Cabezas De Herrera, MD | No disclosure on file |
| Clinton B. Wright, MD, FAAN | An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MARSHALL DENNEHY. The institution of an immediate family member of Dr. Wright has received research support from Oncospace. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO. |
| Tatjana Rundek, MD, PhD | The institution of Dr. Rundek has received research support from NIH. |
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Joseph E. Parisi, MD | Dr. Parisi has nothing to disclose. |
| Charles S. DeCarli, MD, FAAN | Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
| Owen T. Carmichael, PhD | No disclosure on file |
| Valerie E. Wojna, MD, FAAN | Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH. |
| Oscar L. Lopez, MD, FAAN | Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. |
| Leslie Guthery | Leslie Guthery has nothing to disclose. |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Neill R. Graff-Radford, MD, FAAN | The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care. |
| Richard R. Murphy, MBChB, FAAN | Dr. Murphy has nothing to disclose. |
| Meredith N. Braskie | No disclosure on file |
| Carmen Serrano, MD, FAAN | The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie. |
| Angelia Kirkpatrick | Angelia Kirkpatrick has nothing to disclose. |
| Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
| Michael W. Weiner, MD | No disclosure on file |
| Frederick W. Unverzagt, PhD | No disclosure on file |
| Mary Ganguli, MD, MPH | No disclosure on file |
| Virginia J. Howard, PhD | The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH. |
| John Q. Trojanowski, MD, PhD | Dr. Trojanowski has nothing to disclose. |
| Jon B. Toledo | No disclosure on file |
| Hector Gonzalez | No disclosure on file |
| Patricia M. Riccio, MD | No disclosure on file |
| Vladimir Hachinski, MD, DSc, FAAN | Dr. Hachinski has nothing to disclose. |
| Wassim Tarraf | No disclosure on file |
| Nagaendran Kandiah, MD | No disclosure on file |
| Melissa Murray, PhD | Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative. |
| Linda Gallo | Linda Gallo has nothing to disclose. |
| Carolyn Fredericks, MD | The institution of Dr. Fredericks has received research support from Alzheimer's Association. The institution of Dr. Fredericks has received research support from National Institute on Aging. |